Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. (GL) reported third-quarter 2026 net income of $361.107 million, versus $387.843 million a year earlier; diluted net income was $4.62 per share, compared with $4.73. Net operating income, a non-GAAP measure, was $4.84 per diluted share, versus $4.81. Total premium revenue grew 7% to $1,311.409 million, with life premiums up 2% to $864.552 million and health premiums up 16% to $446.857 million.
Life underwriting margin fell 5% to $458.168 million, while health underwriting margin rose 7% to $115.637 million. The United American Division reported a $6.371 million health underwriting loss, primarily due to approximately $16 million of underwriting loss at Evry and approximately $7 million of excess prior-period Medicare Supplement claims tied to a claims-processing delay at the Centers for Medicare and Medicaid Services.
Globe Life adjusted 2026 earnings guidance to $15.35 to $15.65. It estimates 2027 net operating income per share of $16.10 to $17.10, an increase of 7.1% at the midpoint. The company repurchased 1.1 million shares for $185 million at an average share price of $175.61; it expects to spend $725 million to $775 million on 2026 repurchases, versus previous guidance of $670 million to $700 million.
Globe Life Inc. EVP & Chief Investment Officer Robert Edward Hensley exercised 10,000 employee stock options on September 22, 2026, at an exercise price of $103.23, acquiring 10,000 common shares. On the same date, he sold 3,344 shares at a reported $169.5311 per share and 6,656 shares at $170.3409 per share; the respective sale ranges were $168.89 to $169.885 and $169.905 to $170.87. His reported post-transaction employee stock-option position was 23,000, and no Rule 10b5-1 plan is reported.
GLOBE LIFE INC. (GL) received a notice under Rule 144 that executive officer Robert E. Hensley intends to sell 10,000 shares of Globe Life common stock. The shares are associated with a stock option exercise, and the proposed sale date is September 22, 2026 on the NYSE.
Globe Life Inc. shareholder Frank Svoboda filed a notice to sell 16,500 shares of common stock, to be delivered through a stock option exercise with proceeds directed to Globe Life Inc. The filing lists Apex Clearing as the broker and notes trading on the NYSE.
Over the prior three months, Svoboda reported sales of 20,000 shares on May 22, 2026, 10,000 shares on June 11, 2026, and 10,000 shares on June 12, 2026, each in Globe Life common stock.
Globe Life Inc. executive Robert Brian Mitchell, EVP, General Counsel and CRO, exercised 23,000 stock options at an exercise price of $103.23 per share on August 7, 2026, receiving 23,000 shares of common stock. He then sold 23,000 shares in multiple open-market transactions at prices ranging from $182.38 to $185.50 per share. Following these transactions, he continues to hold common stock indirectly through the Mitchell Family Trust, a Son's Trust, and a 401(k) Plan, including shares accumulated via a brokerage dividend reinvestment plan.
Globe Life Inc. reported that board member David A. Rodriguez retired from its Board of Directors effective August 4, 2026, for personal reasons. The company stated that his departure was not the result of any disagreement concerning its operations, policies, or practices.
Globe Life’s common stock, with a par value of $1.00 per share, trades on the New York Stock Exchange under the symbol GL, and its 4.250% Junior Subordinated Debentures trade on the New York Stock Exchange under the symbol GL PRD.
GLOBE LIFE INC. reports that Co-Chairman & CEO James Matthew Darden exercised employee stock options for 50,000 shares of common stock at $98.32 per share on July 31, 2026, then sold 49,600 shares at an average $182.4253 and 400 shares at $183.3575. He also reports 4,202.03 shares held indirectly through a 401(k) plan.
Globe Life Inc. reports its quarterly institutional investment holdings as an investment manager. The report covers a Form 13F Information Table Entry Total of 2 positions, with a combined Form 13F Information Table Value Total of $421,612,883. No other included managers are listed, indicating Globe Life is the sole reporting manager for these positions.